Results 11 to 20 of about 19,093 (217)

Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. [PDF]

open access: yesLancet Infectious Diseases, The, 2017
BACKGROUND: Cryptococcus is the most common cause of meningitis in adults living with HIV in sub-Saharan Africa. Global burden estimates are crucial to guide prevention strategies and to determine treatment needs, and we aimed to provide an updated ...
Angela Loyse   +61 more
core   +5 more sources

Vision loss in an AIDS patient with cryptococcal meningitis

open access: yesMedical Mycology Case Reports, 2019
Cryptococcal meningitis is considered one of the AIDS-defining illness and has been reported to be associated with neurological sequels. However, acute vision loss as presenting complaint is rare in Cryptococcal meningitis.
Wafa Ali Aldhaleei   +2 more
doaj   +1 more source

Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing. [PDF]

open access: yes, 2019
Over the past ten years, standard diagnostics for cryptococcal meningitis in HIV-infected persons have evolved from culture to India ink to detection of cryptococcal antigen (CrAg), with the recent development and distribution of a point-of-care lateral ...
Beyene, T   +5 more
core   +1 more source

Cryptococcal Meningitis in HIV Patients from a Tertiary Care Centre in Northern India [PDF]

open access: yesNational Journal of Laboratory Medicine, 2019
Introduction: Cryptococcal meningitis, caused by Cryptococcus neoformans, an opportunistic fungal infection that affects immunocompromised Human Immunodeficiency Virus (HIV)/ Acquired Immunodeficiency Syndrome (AIDS) patients.
Shiwangi Sharma   +4 more
doaj   +1 more source

Cryptococcus neoformans chitin synthase 3 plays a critical role in dampening host inflammatory responses [PDF]

open access: yes, 2020
Cryptococcus neoformans is the most common disseminated fungal pathogen in AIDS patients, resulting in ∼200,000 deaths each year. There is a pressing need for new treatments for this infection, as current antifungal therapy is hampered by toxicity and/or
Hole, Camaron R   +3 more
core   +2 more sources

Cognitive biases and knowledge deficits leading to delayed recognition of cryptococcal meningitis

open access: yesIDCases, 2019
Cryptococcal meningitis is a potentially devastating infectious complication of immunosuppression best characterized in individuals with HIV. Early recognition of and appropriate antifungal therapy for cryptococcal meningitis has a profound effect on ...
M. Deming   +5 more
doaj   +1 more source

Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance. [PDF]

open access: yes, 2019
Cryptococcal meningitis is a lethal disease with few therapeutic options. Induction therapy with fluconazole has been consistently demonstrated to be associated with suboptimal microbiological and clinical outcomes. Exposure to fluconazole causes dynamic
Aller   +31 more
core   +1 more source

High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients [PDF]

open access: yes, 2017
Background High mortality rates among asymptomatic cryptococcal antigen (CrAg)–positive patients identified through CrAg screening, despite preemptive fluconazole treatment, may be due to undiagnosed cryptococcal meningitis.
Adeboye Adelekan   +34 more
core   +1 more source

Cryptococcal Meningitis and Tuberculous Meningitis Co-infection in HIV-Infected Ugandan Adults. [PDF]

open access: yes, 2018
We report 5 HIV-infected Ugandan adults with cryptococcal and tuberculous (TB) meningitis co-infection. All unmasked meningitis occurred within 5 weeks of starting HIV therapy.
Boulware, David R   +4 more
core   +1 more source

Cryptococcal meningitis: A neglected NTD? [PDF]

open access: yesPLOS Neglected Tropical Diseases, 2017
Although HIV/AIDS has been anything but neglected over the last decade, opportunistic infections (OIs) are increasingly overlooked as large-scale donors shift their focus from acute care to prevention and earlier antiretroviral treatment (ART) initiation.
Molloy, S.F.   +22 more
openaire   +7 more sources

Home - About - Disclaimer - Privacy